Clinical trial
Continuous Levalbuterol for Treatment of Status Asthmaticus in Children
NCT00124176 · Children's Hospital of Philadelphia, Other · Completed
Key facts
| NCT number | NCT00124176 |
|---|---|
| Title | Continuous Levalbuterol for Treatment of Status Asthmaticus in Children |
| Official title | Continuous Levalbuterol for Treatment of Status Asthmaticus in Children |
| Lead sponsor | Children's Hospital of Philadelphia, Other |
| Collaborators | Sumitomo Pharma America, Inc. Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Asthma |
| Intervention type | Drug |
| Interventions | Racemic albuterol (R+S albuterol), Levalbuterol (R albuterol) |
| Enrollment | 81 |
| Start date | Apr 1, 2004 |
| Primary completion | Feb 1, 2006 |
| Completion | Feb 1, 2006 |
| First posted | Jul 27, 2005 |
| Last update posted | Mar 14, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: